StockNews.com began coverage on shares of VBI Vaccines (NASDAQ:VBIV – Free Report) in a report released on Tuesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
VBI Vaccines Stock Performance
VBI Vaccines has a 1-year low of $0.06 and a 1-year high of $1.35. The stock’s fifty day simple moving average is $0.24 and its 200 day simple moving average is $0.49.
VBI Vaccines Company Profile
Want More Great Investing Ideas?
See Also
- Five stocks we like better than VBI Vaccines
- Stock Sentiment Analysis: How it Works
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- What Are Growth Stocks and Investing in Them
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- ETF Screener: Uses and Step-by-Step Guide
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for VBI Vaccines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VBI Vaccines and related companies with MarketBeat.com's FREE daily email newsletter.